Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
Journal of Cutaneous Pathology|September 9, 2017
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemiaSanam Loghavi, Jonathan L Curry, Guillermo Garcia-Manero, et al.
Nature Medicine|January 8, 2025
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trialReinhard Dummer, Caroline Robert, Richard A Scolyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell CarcinomaLaurence Feldmeyer, Courtney W Hudgens, Genevieve Ray-Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers NetworkGuray Akturk, Edwin R Parra, Evisa Gjini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancerAnn W Silk, Christopher A Barker, Shailender Bhatia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2017
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomasJoan Guitart, M Estela Martinez-Escala, Antonio Subtil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in MelanomaY N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid TumorsClinton Yam, Xiaowei Xu, Michael A Davies, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Journal of Cutaneous Pathology|September 9, 2017
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemiaSanam Loghavi, Jonathan L Curry, Guillermo Garcia-Manero, et al.
Nature Medicine|January 8, 2025
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trialReinhard Dummer, Caroline Robert, Richard A Scolyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell CarcinomaLaurence Feldmeyer, Courtney W Hudgens, Genevieve Ray-Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers NetworkGuray Akturk, Edwin R Parra, Evisa Gjini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancerAnn W Silk, Christopher A Barker, Shailender Bhatia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2017
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomasJoan Guitart, M Estela Martinez-Escala, Antonio Subtil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in MelanomaY N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid TumorsClinton Yam, Xiaowei Xu, Michael A Davies, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Pageof 23